Compounds > niacin
Page last updated: 2024-10-19

niacin and Peripheral Vascular Diseases

niacin has been researched along with Peripheral Vascular Diseases in 56 studies

Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research Excerpts

ExcerptRelevanceReference
" In our study, patients were randomized, on average, 6 days after an acute myocardial infarction and/or percutaneous transluminal coronary angioplasty secondary to unstable angina, to pravastatin (combined, when necessary, with cholestyramine and/or nicotinic acid) to achieve low-density lipoprotein cholesterol levels of < or =130 mg/dl (group A, n = 70)."9.09Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). ( Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W, 2000)
" In our study, patients were randomized, on average, 6 days after an acute myocardial infarction and/or percutaneous transluminal coronary angioplasty secondary to unstable angina, to pravastatin (combined, when necessary, with cholestyramine and/or nicotinic acid) to achieve low-density lipoprotein cholesterol levels of < or =130 mg/dl (group A, n = 70)."5.09Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). ( Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W, 2000)
"After an active run-in period, participants were randomly assigned to receive niacin (crystalline nicotinic acid), 3000 mg/d or maximum tolerated dosage (n = 64 with diabetes; n = 173 without diabetes), or placebo (n = 61 with diabetes; n = 170 without diabetes) for up to 60 weeks (12-week active run-in and 48-week double-blind)."2.69Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. ( Brinton, EA; Davis, KB; Egan, D; Elam, MB; Garg, R; Hunninghake, DB; Johnson, C; Kostis, JB; Sheps, DS, 2000)

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-199050 (89.29)18.7374
1990's3 (5.36)18.2507
2000's3 (5.36)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROMANO, G1
VINDIGNI, E1
VECCHI, GP1
RUBBIANI, V1
VOLKMANN, E1
JACQUET, M1
MUTH, HW2
OSTAPOWICZ, G2
UHLMANN, WJ1
HASSE, HM1
MORHARD, WR1
KREBS, P1
HEGER, N1
DEWITZ, A1
HIRSCH, W1
FEINDT, H1
GUAGLIANO, G1
STOPPANI, L1
VASILE, B1
SOMMARIVA, V1
RAPISARDA, LM1
COSSIO, P1
STEINKE, HJ1
ZARRILLI, L2
DE BELLIS, E2
BERGE, T1
JOHANSEN, E1
ASSMANN, F1
CHITIL, W1
ORTNER, H1
BRUNNER, F1
FALK, G1
LERCHE, W1
GENTHOFF, H1
NEIKES, K1
KAPPERT, A1
MAGLIULO, V1
SERRA, GC1
BRUN, F1
PLAUCHU, G1
PERRIN, A1
EHLERS, G1
EHRENBERG, H1
SPERLING, M1
GOLDBERG, S1
GUERRA, G1
JOHNE, HO1
BRANZI, G1
ANNINO, G1
ABRAMSON, DI1
SIVORI, A1
RODRIGUEZNIETO, AJ1
VALLSSERRA, J1
MAZZEO, F1
SPAMPINATO, N1
CORSALE, C1
LIOTTA, S1
KOWALSKA, M1
CUCCO, G1
HAMILTON, RR1
SCHOGER, GA2
SCHOGER-VON SCHOLZ, I1
SIEGENTHALER, P1
PUGLIONISI, A1
TATTONI, G1
DI CIO, AV1
SCHTEINGART, M1
KLEIN, L1
Klinke, JA1
Málek, F1
Gao, M1
Holmes, D1
Frohlich, JJ1
Schectman, G1
Hiatt, J1
Egan, DA2
Garg, R3
Wilt, TJ1
Pettinger, MB2
Davis, KB3
Crouse, J1
Herd, JA1
Hunninghake, DB2
Sheps, DS2
Kostis, JB2
Probstfield, J1
Waclawiw, MA2
Applegate, W1
Elam, MB2
Thomason, T1
Griffin, B1
Johnson, C1
Egan, D1
Brinton, EA1
Arntz, HR1
Agrawal, R1
Wunderlich, W1
Schnitzer, L1
Stern, R1
Fischer, F1
Schultheiss, HP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00000539]Phase 30 participants Interventional1992-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for niacin and Peripheral Vascular Diseases

ArticleYear
Compliance to multiple interventions in a high risk population.
    Annals of epidemiology, 1999, Volume: 9, Issue:7

    Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Antioxidants; Aspirin; Data Interpretation, S

1999
Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.
    JAMA, 2000, Sep-13, Volume: 284, Issue:10

    Topics: Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Double-Blind

2000
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12

    Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemopreven

2000

Other Studies

53 other studies available for niacin and Peripheral Vascular Diseases

ArticleYear
[Tetrahydrofurfuryl ester of nicotinic acid in the treatment of peripheral vascular diseases].
    Gazzetta medica italiana, 1952, Volume: 111, Issue:12

    Topics: Furans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases

1952
[Several cases of peripheral vascular diseases treated with tetrahydrofurfurylic ester of nicotinic acid].
    Minerva medica, 1953, Apr-14, Volume: 44, Issue:30

    Topics: Furans; Humans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Plethysmography

1953
[Nicotinic acid therapy of peripheral circulatory disorders].
    Zentralblatt fur Chirurgie, 1953, Volume: 78, Issue:46

    Topics: Cardiovascular Diseases; Gangrene; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular D

1953
[Local administration of the cobalt salt of benzenesulfonic acid and the chloride or nicotinate salts of the cobalt derivative of hexamine in peripheral circulatory syndromes].
    Archives des maladies du coeur et des vaisseaux, 1954, Volume: 47, Issue:5

    Topics: Benzenesulfonates; Chlorides; Cobalt; Ions; Methenamine; Niacin; Peripheral Vascular Diseases; Salts

1954
[Magnesium nicotinate in arterial blood circulation disorders].
    Deutsches medizinisches Journal, 1956, Sep-15, Volume: 7, Issue:15

    Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular

1956
[Magnesium nicotinate in arterial blood circulation disorders].
    Deutsches medizinisches Journal, 1956, Sep-15, Volume: 7, Issue:15

    Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular

1956
[Magnesium nicotinate in arterial blood circulation disorders].
    Deutsches medizinisches Journal, 1956, Sep-15, Volume: 7, Issue:15

    Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular

1956
[Magnesium nicotinate in arterial blood circulation disorders].
    Deutsches medizinisches Journal, 1956, Sep-15, Volume: 7, Issue:15

    Topics: Cardiovascular Diseases; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular

1956
[Medicinal treatment of peripheral blood circulation disorders].
    Medizinische Klinik, 1956, Sep-28, Volume: 51, Issue:39

    Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera

1956
[Medicinal treatment of peripheral blood circulation disorders].
    Medizinische Klinik, 1956, Sep-28, Volume: 51, Issue:39

    Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera

1956
[Medicinal treatment of peripheral blood circulation disorders].
    Medizinische Klinik, 1956, Sep-28, Volume: 51, Issue:39

    Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera

1956
[Medicinal treatment of peripheral blood circulation disorders].
    Medizinische Klinik, 1956, Sep-28, Volume: 51, Issue:39

    Topics: Bile Acids and Salts; Cardiovascular Diseases; Humans; Magnesium; Niacin; Nicotinic Acids; Periphera

1956
[Differential diagnosis and treatment of red hands with special reference to substances producing hyperemia].
    Die Medizinische, 1957, Feb-16, Issue:7

    Topics: Diagnosis, Differential; Disease; Erythema; Hand; Hyperemia; Niacin; Nicotinic Acids; Peripheral Vas

1957
[Clinical investigations on the effect of intra-arterial infusions of acetylcholine, pyridostigmine bromide and beta-pyridylcarbinol in arterial obliterative diseases].
    Die Medizinische, 1957, May-17, Issue:20

    Topics: Acetylcholine; Infusions, Intra-Arterial; Niacin; Nicotinic Acids; Nicotinyl Alcohol; Parasympathomi

1957
[Treatment of peripheral circulation disorders with progresin].
    Munchener medizinische Wochenschrift (1950), 1957, May-24, Volume: 99, Issue:21

    Topics: Bile Acids and Salts; Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases

1957
[Treatment of peripheral blood circulation disorders with acetylcholine, nicotinic acid derivatives and cholinesterase antagonists].
    Wiener medizinische Wochenschrift (1946), 1957, Jul-13, Volume: 107, Issue:28

    Topics: Acetylcholine; Cardiovascular Diseases; Cholinesterases; Niacin; Nicotinic Acids; Parasympathomimeti

1957
[Policlinical contribution to the treatment of peripheral arterial circulation disorders].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1957, Apr-01, Volume: 12, Issue:7

    Topics: Bile Acids and Salts; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Dise

1957
[Clinical contribution to the treatment of autonomic circulation disorders].
    Medizinische Klinik, 1957, Aug-30, Volume: 52, Issue:35

    Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Cardiovascular Diseases; Humans; Niacin

1957
[Treatment of peripheral vascular diseases in tuberculous patients with progresin].
    Die Medizinische, 1957, Nov-30, Volume: 25, Issue:48

    Topics: Bile Acids and Salts; Humans; Magnesium; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Salt

1957
[Nicotinamide hydroiodide in the treatment of degenerative arterial diseases].
    Minerva medica, 1957, Oct-24, Volume: 48, Issue:85

    Topics: Humans; Niacin; Niacinamide; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1957
[Proposed new durg cocktail in medical therapy of chronic obliterating arteriopathy].
    Gazzetta medica italiana, 1958, Volume: 117, Issue:3

    Topics: Anti-Allergic Agents; Ergot Alkaloids; Hibernation; Histamine H1 Antagonists; Hypothermia, Induced;

1958
[Changes in the electrophoretic picture of lipoproteins and glycoprotein fractions in arterial and venous blood of patients of arterial diseases after drug cocktail therapy].
    Rivista di patologia e clinica, 1958, Volume: 13, Issue:2

    Topics: Blood Proteins; Electrophoresis; Ergot Alkaloids; Histamine H1 Antagonists; Lipoproteins; Niacin; Pa

1958
The treatment of angina pectoris and other muscular pain due to ischemia with iproniazid and isoniazid.
    American heart journal, 1958, Volume: 56, Issue:1

    Topics: Angina Pectoris; Humans; Iproniazid; Ischemia; Isoniazid; Niacin; Nicotinic Acids; Peripheral Vascul

1958
[Therapeutic effects of various nicotinic acid derivatives in peripheral & cerebral circulatory disorders].
    Zentralblatt fur Chirurgie, 1958, Volume: 83, Issue:7a

    Topics: Brain; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1958
[Elimination of nicotinic acid in patients with chronic obstructive arteriopathy of the lower extremities].
    Giornale italiano di chirurgia, 1958, Volume: 14, Issue:4

    Topics: Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1958
[Elimination of N'-methylnicotinamide in patients with arteriopathies after surgical intervention].
    Giornale italiano di chirurgia, 1958, Volume: 14, Issue:5

    Topics: Niacin; Niacinamide; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1958
[Hexanicit in arterial insufficiency of the lower extremities].
    Svenska lakartidningen, 1958, Nov-28, Volume: 55, Issue:48

    Topics: Humans; Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1958
[Therapy of peripheral blood circulation disorders with reference to diabetic gangrene].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1959, Volume: 30, Issue:2

    Topics: Diabetes Complications; Diabetic Angiopathies; Gangrene; Humans; Niacin; Nicotinic Acids; Peripheral

1959
[Peripheral blood circulation disorders and their physical treatment with special reference to iontophoresis with nicotinates].
    Wiener medizinische Wochenschrift (1946), 1959, Apr-04, Volume: 109, Issue:14

    Topics: Cardiovascular Diseases; Ion Exchange; Iontophoresis; Niacin; Nicotinic Acids; Peripheral Vascular D

1959
[Clinical experiences with the nicotinic acid ester of hydroxyethltheophylline (hesotin) in the treatment of cerebral & peripheral circulation disorders].
    Wiener medizinische Wochenschrift (1946), 1959, Jun-06, Volume: 109, Issue:23

    Topics: Brain; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascular Diseases

1959
[Clinical contribution to the treatment of peripheral circulation disorders with Complamine].
    Medizinische Monatsschrift, 1961, Volume: 15

    Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul

1961
[A contribution to improvement in the results of surgery of the sympathetic nervous system (with a study on blood supply of the muscles)].
    Die Medizinische Welt, 1960, Nov-19, Volume: 47

    Topics: Muscles; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Sympathectomy; Sympathetic Nervous S

1960
[Nicotinic acid in the treatment of vascular diseases].
    Die Medizinische Welt, 1960, Sep-17, Volume: 38

    Topics: Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1960
[Experimental and clinical experiences with Complamine in disorders of cerebral and peripheral circulation].
    Praxis, 1961, Aug-24, Volume: 50

    Topics: Brain; Cardiovascular System; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; V

1961
[The hexa-nicotinic acid ester of m-inositol in the treatment of peripheral vascular diseases. Clinical results].
    Minerva medica, 1961, May-23, Volume: 52

    Topics: Hexosaminidase A; Humans; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular

1961
[Demonstration on a trial treatment with Euclidan injected by the intra-arterial route of severe ischemic conditions of the lower limbs].
    Lyon medical, 1962, Jun-03, Volume: 94

    Topics: Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Vasodilat

1962
[Experiences in the treatment of arterial and venous blood circulation disorders, including ulcus cruris, with a nicotinic acid-xanthine derivative].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1961, Dec-01, Volume: 31

    Topics: Humans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Ulcer; Varicose Ulcer; Vascular Disea

1961
[Results of long-term therapy with Complamin].
    Hippokrates, 1961, Dec-15, Volume: 32

    Topics: Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascular Diseases; Xanthinol Ni

1961
[Clinical trial of the treatment of peripheral circulation disorders with Complamine].
    Munchener medizinische Wochenschrift (1950), 1962, Jul-06, Volume: 104

    Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul

1962
[Magnesium compositum-a new medication for the treatment of peripheral arterial circulatory disorders].
    Zeitschrift fur arztliche Fortbildung, 1963, Mar-01, Volume: 57

    Topics: Humans; Magnesium; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Disease

1963
[Our experience with tetranicotinoyl-fructose in the treatment of peripheral vascular diseases].
    La Riforma medica, 1962, Sep-01, Volume: 76

    Topics: Fructose; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Vasodilator Agen

1962
[Experiences in the treatment of peripheral vascular diseases with Lipocapsul].
    Die Medizinische Welt, 1963, Apr-06, Volume: 14

    Topics: Amino Alcohols; Fatty Acids; Humans; Inositol; Intermittent Claudication; Leg Ulcer; Niacin; Periphe

1963
[Therapy of peripheral arteriopathies with a compound with a base of inositol hexanicotinate].
    La Riforma medica, 1963, Jan-19, Volume: 77

    Topics: Inositol; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Diseases; Pyrido

1963
DRUGS USED IN PERIPHERAL VASCULAR DISEASES.
    The American journal of cardiology, 1963, Volume: 12

    Topics: Deoxyribonuclease I; Dihydroergotoxine; Endopeptidases; Ergot Alkaloids; Ganglionic Blockers; Histam

1963
[CURRENT THERAPY OF PERIPHERAL VASCULAR DISEASES].
    El Dia medico, 1964, Mar-16, Volume: 36

    Topics: Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Xanthines

1964
[CLINICAL STUDY OF TETRANICOTINOYLFRUCTOSE IN THE TREATMENT OF PERIPHERAL ANGIOPATHIES].
    Medicina clinica, 1964, Volume: 42

    Topics: Amputation Stumps; Anticoagulants; Biomedical Research; Fructose; Humans; Hypertension; Niacin; Nico

1964
[3-(METHYLHYDROXYETHYLAMINO)-2-HYDROXYPROPYLTHEOPHYLLINE NICOTINATE IN THE TREATMENT OF PERIPHERAL ARTERIOPATHIES].
    Rassegna internazionale di clinica e terapia, 1964, Sep-15, Volume: 44

    Topics: Angiography; Drug Therapy; Geriatrics; Humans; Niacin; Nicotinic Acids; Peripheral Arterial Disease;

1964
[FIRST EXPERIENCES ON THE THERAPEUTIC ACTIVITY OF M-INOSITOL HEXANICOTINATE AND KALLIKREIN IN PERIPHERAL VASCULAR DISEASES AND IN CORONARY DISEASE].
    Il Policlinico. Sezione pratica, 1964, Dec-21, Volume: 71

    Topics: Coronary Disease; Electric Impedance; Electrocardiography; Humans; Kallikreins; Niacin; Nicotinic Ac

1964
[VASPERDIL IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES].
    Therapeutische Umschau. Revue therapeutique, 1964, Volume: 21

    Topics: Drug Therapy; Fructose; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1964
[Diverse pharmacodynamic action of vasomotor drugs on peripheral circulation; experimental research on the blood-ciliary barrier and conclusions regarding clinical practice and therapy].
    Annali di ottalmologia e clinica oculistica, 1955, Volume: 81, Issue:2

    Topics: Humans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1955
Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
    The Practitioner, 1960, Volume: 184

    Topics: General Practice; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases

1960
[Results of inositol-nicotinic acid therapy in the treatment of blood circulation disorders].
    Zeitschrift fur Rheumaforschung, 1959, Volume: 18

    Topics: Cardiovascular Diseases; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular D

1959
[On the appropriate treatment of peripheral circulation disorders in private practice].
    Therapie der Gegenwart, 1960, Volume: 99

    Topics: Cardiovascular Diseases; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Private Pr

1960
[The influence on peripheral circulation disorders and on blood cholesterol of a nicotinic acid derivative (ES 304), administered in high doses].
    Praxis, 1960, Jun-23, Volume: 49

    Topics: Cardiovascular Diseases; Cholesterol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascula

1960
[Effect of tetrahydro-furfuryl ester of nicotinic acid (Trafuril) in the therapy of peripheral arteriopathy].
    Minerva chirurgica, 1952, Apr-15, Volume: 7, Issue:7

    Topics: Arteries; Furans; Niacin; Nicotinic Acids; Peripheral Vascular Diseases

1952
[Effect of associated sodium citrate and sodium phosphate with nicotinic acid in certain peripheral vascular diseases].
    Prensa medica argentina, 1952, Jul-11, Volume: 39, Issue:28

    Topics: Citrates; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Phosphates; Sodium Citrate

1952
Reaching target lipid levels in patients at high risk of cardiovascular event: the experience of a Canadian tertiary care lipid clinic.
    Central European journal of public health, 2007, Volume: 15, Issue:3

    Topics: Body Mass Index; Canada; Cardiovascular Diseases; Cohort Studies; Diabetes Complications; Dyslipidem

2007
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
    The American journal of medicine, 1996, Volume: 100, Issue:2

    Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Colestipol; Coronary Disease; Female; Gemfibrozil;

1996
Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study.
    The American journal of cardiology, 1999, Feb-15, Volume: 83, Issue:4

    Topics: Adult; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mi

1999